Benzinga's Top Upgrades (TRN, ANF, CAM, GSK)
Trinity Industries Inc (NYSE: TRN) was upgraded by BB&T Capital from "hold" to "buy." TRN's shares closed at $30.46 on Friday. TRN's trailing-twelve-month revenue is $2.05 billion.
Wells Fargo upgraded Abercrombie & Fitch Co (NYSE: ANF) from "market perform" to "outperform." ANF's shares closed at $54.89 on Friday. Abercrombie & Fitch's trailing-twelve-month revenue is $3.26 billion.
RBC Capital upgraded Cameron International Corporation (NYSE: CAM) from “sector perform” to “outperform.” CAM's shares closed at $56.54 on Friday. Cameron International's trailing-twelve-month ROE is 13.54%.
Analysts at Exane BNP Paribas upgraded GlaxoSmithKline plc (NYSE: GSK) from “neutral” to “outperform.” GSK's shares closed at $37.75 on Friday. GlaxoSmithKline's trailing-twelve-month operating margin is 32.35%.
